Brandt Peter C.
Known title: DirectorCIK: 0001434099
Brandt Peter C.'s purchase track record
Brandt Peter C. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/16/2022 | INAB | $200K | -15.3% | +1.9% | -3.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| INAB | ▲ Buy | Grant | 72,464 | $100K | 12/22/2025 | View on chart |
| INAB | ▲ Buy | Option Exercise | 81,967 | $15K | 4/30/2025 | View on chart |
| INAB | ▲ Buy | Option Exercise | 81,967 | $15K | 4/30/2025 | View on chart |
| INAB | ▲ Buy | Grant | 253,164 | — | 10/4/2024 | View on chart |
| INAB | ▲ Buy | Grant | 81,967 | — | 12/13/2023 | View on chart |
| INAB | ▲ Buy | Open Market | 105,263 | $200K | 8/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
IN8bio Reports Inducement Grant Under Nasdaq Rule
IN8bio disclosed an inducement grant in compliance with Nasdaq Listing Rule 5635(c)(4). This filing is a standard corporate governance procedure used to attract or retain key employees. The stock is currently trading near its 52-week high, with technical indicators showing recent support rejection.
IN8bio Reports Inducement Grant Under Nasdaq Rule. IN8bio disclosed an inducement grant in compliance with Nasdaq Listing Rule 5635(c)(4). This filing is a standard corporate governance procedure used to attract or retain key employees. The stock is currently trading near its 52-week high, with technical indicators showing recent support rejection.